{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:47:04Z","timestamp":1769208424311,"version":"3.49.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Int. J. Hematol. Oncol."],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.2217\/ijh-2018-0004","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T10:07:39Z","timestamp":1531303659000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Chart Review Across EU5 in MM Post-ASCT Patients"],"prefix":"10.2217","volume":"7","author":[{"given":"John","family":"Ashcroft","sequence":"first","affiliation":[{"name":"Department of Haematology, Mid-Yorkshire NHS Trust, Wakefield, WF1 4DG2, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davneet","family":"Judge","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, Cheshire, SK10 5JB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujith","family":"Dhanasiri","sequence":"additional","affiliation":[{"name":"Celgene International, Boudry, CH-2017, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Taylor-Stokes","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, Cheshire, SK10 5JB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Middleton","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, Cheshire, SK10 5JB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1283"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.07.007"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx096"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-358812"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-568915"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328324bc04"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.83"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-015-0826-3"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114138"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14193"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0023"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.6679"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.8017"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114083"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.8018"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2009.01153.x"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089161309900434"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1031732"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.07.025"},{"issue":"7","key":"e_1_3_5_22_1","first-page":"19","article-title":"Economic and clinical impact of multiple myeloma to managed care","volume":"14","author":"Cook R","year":"2008","unstructured":"Cook R. Economic and clinical impact of multiple myeloma to managed care. J. Manag. Care Pharm. 14(Suppl. 7), 19\u201325 (2008).","journal-title":"J. Manag. Care Pharm."},{"issue":"4","key":"e_1_3_5_23_1","first-page":"187","article-title":"The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients","volume":"4","author":"Meehan KR","year":"2006","unstructured":"Meehan KR, Fitzmaurice T, Root L et al. The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients. J. Support. Oncol. 4(4), 187\u2013190 (2006).","journal-title":"J. Support. Oncol."},{"key":"e_1_3_5_24_1","volume-title":"22nd Congress of the European Hematology Association","author":"Rifkin RM","year":"2017","unstructured":"Rifkin RM, Jagannath S, Durie BGM et al. E1277 analysis of the connect MM registry: treatment outcomes and healthcare resource utilization in patients with newly diagnosed multiple myeloma who received lenalidomide maintenance or no maintenance [Eposter presentation]. Presented at: 22nd Congress of the European Hematology Association. Madrid, Spain, 22\u201325 June 2017."},{"key":"e_1_3_5_25_1","volume-title":"Stata Statistical Software: Release 15","author":"StataCorp","year":"2017","unstructured":"StataCorp. Stata Statistical Software: Release 15. StataCorp LLC, College Station, TX, USA, 2017. www.stata.com\/support\/faqs\/resources\/citing-software-documentation-faqs\/."},{"key":"e_1_3_5_26_1","unstructured":"European Medicines Agency. Revlimid assessment report EMA\/CHMP\/108277\/2017.www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000717\/WC500225259.pdf."},{"key":"e_1_3_5_27_1","unstructured":"Tolerability and efficacy of post transplant lenalidomide maintenance therapy in multiple myeloma: a real world single centre experience.Blood J. www.bloodjournal.org\/content\/130\/Suppl_1\/3462?sso-checked=true."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14213"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12384"},{"key":"e_1_3_5_30_1","volume-title":"13th Hematology\/Oncology Pharmacy Association Annual Conference","author":"Leblebjian H","year":"2017","unstructured":"Leblebjian H. Navigating new treatment paradigms in relapsed or refractory multiple myeloma. Presented at: 13th Hematology\/Oncology Pharmacy Association Annual Conference. Anaheim, CA, USA, 29 March\u20131 April 2017."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19269"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.02.007"},{"key":"e_1_3_5_33_1","volume-title":"ASH 58th Annual Meeting & Exposition","author":"Abonour R","year":"2016","unstructured":"Abonour R, Durie BGM, Jagannath S et al. 537 health-related quality of life of patients with newly diagnosed multiple myeloma receiving any or lenalidomide maintenance after autologous stem cell transplant in the Connect MM Disease Registry [oral abstract]. Presented at: ASH 58th Annual Meeting & Exposition. San Diego, CA, USA, 3\u20136 December 2016."}],"container-title":["International Journal of Hematologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/ijh-2018-0004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:12:36Z","timestamp":1717233156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/ijh-2018-0004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.2217\/ijh-2018-0004"],"URL":"https:\/\/doi.org\/10.2217\/ijh-2018-0004","relation":{},"ISSN":["2045-1393","2045-1407"],"issn-type":[{"value":"2045-1393","type":"print"},{"value":"2045-1407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iijh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iijh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"IJH05"}}